<unk>  is an aminoglycoside antibiotic that displays bactericidal activity against gram-negative aerobic bacilli and some anaerobic bacilli where resistance has not yet arisen. It is generally not effective against gram-positive bacilli and anaerobic gram-negative bacilli.<unk>  comes in oral and topical formulations, including creams, ointments, and eyedrops.<unk>  belongs to the aminoglycoside class of antibiotics that contain two or more amino sugars connected by glycosidic bonds.<unk>  was discovered in 1949 by microbiologist Selman Waksman and his student Hubert Lechevalier at Rutgers University.<unk>  received approval for medical use in 1952. Rutgers University was granted the patent for<unk>  in 1957.
Neomycin
Dactinomycin
Anisomycin
Paromomycin
Capreomycin
Boromycin
Bicyclomycin
Valrubicin